Home » Newsletters » BioWorld Science

BioWorld Science

April 10, 2003

View Archived Issues

Frovatriptan in cluster headache and menstrually associated migraine

New data on alitretinoin and bexarotene in dermatological disorders

Infliximab effective and well tolerated in plaque psoriasis

Adjunctive levetiracetam for pain relief in multiple sclerosis

Use of topiramate in the prevention of migraine attacks

New HIV reverse transcriptase inhibitors in Medivir research pipeline

Another series of angiogenesis inhibitors identified at Merck

Dual LH and FSH receptor agonists discovered at Akzo Nobel

Aminopyrrole p38 kinase inhibitors in early development at Roche

Zentaris researchers prepare and test new antitumor agents

Inotek claims PARP inhibitors with activity in inflammation, reperfusion and diabetes models

New benzothiazepine-based IBAT inhibitors discovered at AstraZeneca

Pharmexa seeks approval in Europe for phase II HER-2 DNA AutoVac trial

Oral phenoxodiol tested in phase II study for skin cancer

Patient dosing under way in new phase IIa trial of dexanabinol

Sunol Molecular initiates trial to combat complications from E. coli infections

COX-2 inhibition as a novel therapeutic approach in Parkinson's disease

Vinorelbine TCS selected for development

Worldwide status of Replagal updated by TKT

Jerini decapeptide designated orphan drug for angioedema

Clinical testing of Tbeta4 begins at RegeneRx

Lilly and Sankyo advance CS-747 to phase II

Choongwae will market mitiglinide in Korea

First-in-man study of Probiodrug DPP-IV inhibitor

ASCOT data demonstrate significant cardiovascular benefits for Lipitor

NDA filed for Tracleer in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...